Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
Foram publicadas três experiências comparavando a reboxitina  com outros antidepressivos em que a reboxitina era igualmente boa,  e esses foram publicados. Mas o triplo dos dados que foram reunidos e que mostravam que a reboxetina era pior do que os outros tratamentos, essas experiências não foram publicadas.